International registries show PCI rates increased in Japan, US
(American College of Cardiology) Japan and the US have seen an increase in percutaneous coronary intervention (PCI) procedures, which is driven primarily by a rise in elective PCIs in Japan compared to non-elective in the U.S., according to a study in the Journal of the American College of Cardiology. Since adoption of large-scale PCI trial results vary internationally, the study sought to analyze large national registries in both countries to illuminate international variation in PCI practice as a foundation for further quality improvement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2020 Category: International Medicine & Public Health Source Type: news

Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction, Heart
Study (n=34,127) found decline by 43% in the number of PCI procedures for STEMI in April 2020 vs the average between 2017 and 2019, but the in-hospital mortality rate was not higher during the lockdown (3.5% vs 4.8% before the lockdown). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 3, 2020 Category: Consumer Health News Source Type: news

Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease
SINGAPORE, Aug. 27, 2020 -- (Healthcare Sales & Marketing Network) -- Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the FUTURE BTK trial (Randomized Controlled Trial of Fi... Devices, Interventional Concept Medical, critical limb ischemia, angioplasty, MagicTouch PTA, sirolimus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 27, 2020 Category: Pharmaceuticals Source Type: news

Genetic testing cut adverse events in heart patients
Personalized genetic testing led to a 34% decrease in the number of patients...Read more on AuntMinnie.comRelated Reading: USPSTF advises against carotid artery stenosis screening Abbott recalls 2 coronary angioplasty catheters FDA offers guidance on angioplasty and specialty catheters USPSTF opens review of carotid stenosis screening Coronary CTA beats stress test for changing lifestyles (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 27, 2020 Category: Radiology Source Type: news

Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet therapy
ROCHESTER, Minn. ? Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement? nonsurgical procedures to improve blood flow to the heart ? are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - August 25, 2020 Category: Hospital Management Source Type: news

What Are the Main Acyanotic Congenital Heart Diseases?
Discussion Congenital heart diseases (CHD) are malformations of the heart and great vessels. It occurs in about 5-8/1000 live births. Cyanotic congenital heart disease is often noted perinatally because of cyanosis, respiratory distress and/or poor feeding or other distress type problems. A review can be found here. Acyanotic congenital heart disease (ACHD) can present at birth but often is seen in older children or adults unless the lesions are severe, especially obstructive lesions. Severe lesions may also cause cyanosis and distress type problems in patients also. Shunting lesions cause problems by diverting blood flo...
Source: PediatricEducation.org - August 17, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Black Patients Fare Worse After Angioplasty
Even after undergoing the artery-clearing procedure angioplasty, Black patients with heart disease are more likely than whites to suffer a heart attack or die within the next several years. (Source: WebMD Health)
Source: WebMD Health - July 7, 2020 Category: Consumer Health News Source Type: news

Black Patients Fare Worse After Angioplasty
MONDAY, July 6, 2020 -- Even after undergoing the artery-clearing procedure angioplasty, Black patients with heart disease are more likely than whites to suffer a heart attack or die within the next several years. That's the conclusion of a new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 6, 2020 Category: General Medicine Source Type: news

Black patients have higher rates of death after PCI
(American College of Cardiology) Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major adverse outcomes, including death, compared to white patients, according to a study published today in JACC: Cardiovascular Interventions. The study underscores the high rates of cardiovascular disease and risk factors in minorities and continued need for further research on race-based outcomes after cardiovascular procedures, including PCI, to understand and alleviate these differences. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 6, 2020 Category: International Medicine & Public Health Source Type: news

MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
NYON, Switzerland, June 30, 2020 -- (Healthcare Sales & Marketing Network) -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease. ... Devices, Interventional, Cardiology, Regulatory MedAlliance, SELUTION SLR, Sirolimus, Drug Eluting Balloon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 30, 2020 Category: Pharmaceuticals Source Type: news

New Research Finds Abbott's Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages
-- Using optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI), physicians were able to select the right size stents and place them with greater precision (Source: Abbott.com)
Source: Abbott.com - June 26, 2020 Category: Pharmaceuticals Source Type: news

ABRE Study Meets Primary Safety and Effectiveness Endpoints
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first-ever results from the ABRE clinical study assessing the safety and effectiveness of the investigational Abre ™ venous self-expanding stent system in subjects with iliofemoral venous outflow obstruction. The study met the primary safety and effectiveness endpoints, and the data were presented today virtually via the 2020 Charing Cross Symposium. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - June 17, 2020 Category: Cardiology Source Type: news

Medtronic Expands Indications for the Resolute Onyx DES in Europe
Medtronic has scored CE mark for a unique indication for the Resolute Onyx drug-eluting stent. The Dublin-based company said the approval was for a DAPT indication for high bleeding risk (HBR) patients. The firm said for HBR patients whose bleeding risk may be increased by taking longer DAPT regimens (a combination of aspirin and anti-clotting medication), this new, indication allows physicians to recommend a shorter, one-month regimen of DAPT, following a percutaneous coronary intervention (PCI) with Resolute Onyx. The indication is based on results from the Onyx ONE Global Study, a prospective, randomized, one-month DAPT...
Source: MDDI - June 8, 2020 Category: Medical Devices Authors: MDDI Staff Tags: Regulatory and Compliance Cardiovascular Source Type: news

Abiomed Granted IDE to Evaluate ‘World’s Smallest Heart Pump’
Abiomed said it has received approval for an IDE to start an early feasibility study of what it is calling the “world’s smallest heart pump.”   The Danvers, MA-based company said the first-in-human trial will look at the 9 French Impella ECP heart pump in high-risk percutaneous coronary intervention (PCI) patients.   The primary endpoint of the study is successful delivery, initiation, and maintenance of adequate hemodynamic support and a composite rate of major device-related adverse events during high-risk PCI.   The stu...
Source: MDDI - June 6, 2020 Category: Medical Devices Tags: Cardiovascular Regulatory and Compliance Source Type: news

FDA Clears Innovative Angioplasty Scoring and Cutting Platform
New metal-alloy sheath converts angioplasty balloons into scoring and cutting systems PARK CITY, Utah, June 4, 2020 -- (Healthcare Sales & Marketing Network) -- Transit Scientific announced the FDA cleared the XO Score® Percutaneous Transluminal An... Devices, Interventional, FDA Transit Scientific, XO Score, Scoring Sheath, Angioplasty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 4, 2020 Category: Pharmaceuticals Source Type: news

Two paths better than one for treating patients with heart stents
(University of Alberta Faculty of Medicine& Dentistry) Pairing a blood-thinning drug with aspirin daily for patients who have an angioplasty with a stent can contribute to better health outcomes, including lower risk of death, than aspirin alone, according to a recent study by cardiologists at the University of Alberta and Mazankowski Alberta Heart Institute. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2020 Category: International Medicine & Public Health Source Type: news

Primary PCI Remains Standard of Care for STEMI During COVID-19
WEDNESDAY, April 29, 2020 -- Primary percutaneous coronary intervention (PCI) remains the standard of care for patients with ST-elevation myocardial infarction (STEMI) during the COVID-19 pandemic, according to a consensus statement published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 29, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 Business Updates Provide Some Clarity
The unknowns still outnumber the knowns, but recent business updates provide some clarity around how the medical device industry is fairing during the COVID-19 pandemic. First and foremost, it is clear that companies are hurting in the areas of elective procedures, which are being deferred. But there may be some silver linings hidden amongst the bad news. Needham & Co. medtech analyst Mike Matson estimates that medical device sales across the industry will continue to drop by an average of 40% to 50% until the economy begins to reopen and hospitals start to resume elective procedures. Matson's e...
Source: MDDI - April 10, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Business Source Type: news

Cardiac Arrest Deaths at Home in New York City Have Increased By a Startling 800%
There's been a 50% or more drop in the number of people receiving emergency treatment for heart attacks in many hospitals. Physicians have been speculating why this might be. Now frightening numbers from New York City's overwhelmed emergency medical system may provide part of the answer: hundreds of people a day have been dying of cardiac arrest in their homes, an eight-fold increase over the same period last year. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - April 8, 2020 Category: Cardiology Source Type: news

CABG Tied to Lower Death Rate in MI Complicated by Cardiogenic Shock CABG Tied to Lower Death Rate in MI Complicated by Cardiogenic Shock
Coronary-artery-bypass grafting (CABG) is associated with lower in-hospital mortality in myocardial infarction (MI) complicated by cardiogenic shock, compared with percutaneous coronary intervention (PCI), according to a database study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 7, 2020 Category: Surgery Tags: Cardiology News Source Type: news

Doctors Say: Don't Sit Out a Heart Attack at Home
Since the onset of the novel coronavirus COVID-19, hospital emergency departments have seen a precipitous drop in the number of heart attack patients presenting for treatment. The big question is why? Are there really less heart attacks occurring, or are patients staying home, afraid to come to the hospital for fear of contracting the virus? There's good reason to believe that the latter may be the case, and the implications are extremely troubling. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - April 7, 2020 Category: Cardiology Source Type: news

Shockwave Completes Enrollment in Pivotal Study for Coronary Intravascular Lithotripsy
Shockwave Medical, Inc. (NASDAQ: SWAV) announced today that the company has completed enrollment in the pivotal U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study – DISRUPT CAD III – for the use of IVL in heavily calcified coronary arteries. The investigational Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, which has been granted Breakthrough Device Designation by the FDA, is an innovative therapy designed to fracture problematic calciu m using sonic pressure waves in order to facilitate stent delivery, deployment and optimal expansion. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - April 6, 2020 Category: Cardiology Source Type: news

TWILIGHT Benefits of Dropping Aspirin Hold Up in Diabetes TWILIGHT Benefits of Dropping Aspirin Hold Up in Diabetes
Treatment with ticagrelor alone shows no increase in bleeding, MI, or stroke after percutaneous coronary intervention in the TWILIGHT trial subanalysis.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 1, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Genetic testing for antiplatelet therapy post-PCI misses cut in cardiovascular events
(American College of Cardiology) An international clinical trial that used genetic testing to guide which antiplatelet medication was given to patients following percutaneous coronary intervention (PCI) did not meet its stated goal for cutting in half the incidence of serious adverse cardiovascular events, such as heart attack and stroke, in the year following the procedure, according to study results presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 30, 2020 Category: Biology Source Type: news

Location of Coronary-artery Lesion Not Tied to Stenting Outcome Location of Coronary-artery Lesion Not Tied to Stenting Outcome
The outcomes of percutaneous coronary intervention (PCI) with new-generation drug-eluting stents (DES) in patients with proximal left anterior descending (P-LAD) coronary-artery lesions appear similar to those seen in patients with lesions in other segments, according to data from three clinical trials.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2020 Category: Consumer Health News Tags: Medscape Today News Source Type: news

CTO PCI Linked to Worse Outcomes in Patients With Prior CABG CTO PCI Linked to Worse Outcomes in Patients With Prior CABG
Observational data show less technical success and worse outcomes with angioplasty of chronic total occlusions after bypass surgery. Such procedures should be limited to expert centers, researchers say.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 24, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Philips Ramps Up Production of Critical Health Technology Products in Response to COVID-19 Pandemic
Philips is ramping up the production of hospital ventilators and plans to double production within the next eight weeks and achieve a four-fold increase by the third quarter of 2020. The company is mobilizing its global supplier network to step up support and production in this extraordinary situation. Philips has a global manufacturing footprint with final assembly sites in North America, Europe and Asia, and, equally important, a global network of certified materials and component suppliers. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - March 23, 2020 Category: Cardiology Source Type: news

Medtronic Has Ramped Up Ventilator Production
Medtronic, manufacturer of the Puritan Bennett line of ventilators, reports that they have already increased their production by 40% and are "on track" to achieve twice their normal output. Manufactured in Galway, Ireland, Medtronic's workforce numbers 250. The company is doubling that, bringing in new people and transferring staff from other Medtronic sites, and reconfiguring its plant to operate 24/7. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - March 20, 2020 Category: Cardiology Source Type: news

Dual Therapy Linked to Lower Bleeding Risk in A-Fib After PCI
MONDAY, March 16, 2020 -- For patients with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy is associated with a reduced risk for bleeding compared with triple therapy, according to research published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2020 Category: Pharmaceuticals Source Type: news

Cracking (the Code of) CAC to Win the Last Battle of PCI Cracking (the Code of) CAC to Win the Last Battle of PCI
A new study elucidates the underlying mechanism for an increased risk when treating calcified lesions during percutaneous coronary intervention with newer generation drug-eluting stents.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 6, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

2003 to 2016 Saw Changes in Characteristics of PCI, CABG Patients
MONDAY, March 2, 2020 -- Between 2003 and 2016, there were decreases in in-hospital mortality after coronary artery bypass grafting (CABG) but not after percutaneous coronary intervention (PCI), according to a study published online Feb. 14 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 2, 2020 Category: Pharmaceuticals Source Type: news

Abbott recalls 2 coronary angioplasty catheters
Pharmaceutical and healthcare company Abbott Laboratories has issued a voluntary...Read more on AuntMinnie.comRelated Reading: FDA clears Abbott's ICD for use with MRI Abbott, CARO reach 10-year milestone Abbott to bring Xience V to China Abbott takes Xience Prime stent overseas Medtronic, Abbott bury patent-dispute hatchet (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 25, 2020 Category: Radiology Source Type: news

Philips Seeks Better Understanding of PCI Outcomes Through New Trial
Philips is continuing its investment into percutaneous coronary intervention (PCI) procedures through a new study. The company announced the (Distal Evaluation of Functional performance with Intravascular sensors to assess the Narrowing Effect: Guided Physiologic Stenting) (DEFINE GPS) global multicenter study, which has a goal to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images. The announcement of the study comes on the heels of Philips making a bid to shed its appliances unit so it can focus on healthcare.  The primary endpoint is target vessel failure (a composite o...
Source: MDDI - February 21, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Imaging Source Type: news

Polymer-Based Stents Noninferior for Patients With High Bleeding Risk
THURSDAY, Feb. 20, 2020 -- Polymer-based zotarolimus-eluting stents are noninferior to polymer-free drug-coated stents among patients at high bleeding risk undergoing percutaneous coronary intervention (PCI), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 20, 2020 Category: Pharmaceuticals Source Type: news

Medtronic Begins New Pilot Study as Part of SPYRAL HTN Clinical Program for Renal Denervation in Hypertension Patients
Medtronic plc (NYSE:MDT) today announced it will begin enrollment in a pilot study evaluating the safety and efficacy of the Symplicity ™ Spyral renal denervation (RDN) system using a targeted procedural approach with a reduced number of radio frequency (RF) ablations. Set to enroll 50 patients at up to 15 sites in the U.S. and Europe, the single-arm study is designed to focus on ablating the distal main renal artery and primary b ranches to lower blood pressure utilizing a simplified procedural approach. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 4, 2020 Category: Cardiology Source Type: news

Biodegradable Coronary Stents Better Than Durable Stents in Registry Study Biodegradable Coronary Stents Better Than Durable Stents in Registry Study
Patients with acute myocardial infarction (MI) who underwent percutaneous coronary intervention (PCI) had better outcomes with biodegradable polymer drug-eluting stents (BP-DES) than with second-generation durable polymer drug-eluting stents (DP-DES), a South Korean registry study found.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 17, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

U.S. Prices For Healthcare Services Far Outpace Peer Nations
The fact that angioplasties and hospital stays are much more expensive in the U.S. is not reflective of angioplasties or hospital stays being better in the U.S. Hospitals in the U.S. charge $32,000 for an angioplasty because they can in a market with non-competitive features. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 15, 2020 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Source Type: news

FDA offers guidance on angioplasty and specialty catheters
The U.S. Food and Drug Administration (FDA) has issued a draft guidance for...Read more on AuntMinnie.comRelated Reading: FDA offers guidance on coated devices Cinematic rendering offers clinical utility in MSK CT Coronary CTA beats stress test for changing lifestyles Medtronic launches new endoscopic catheter r4 Vascular gets FDA clearance for PTA balloon (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 10, 2020 Category: Radiology Source Type: news

Today, the @US_FDA issued the draft guidance: Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters – Premarket Notification (510(k)) Submissions.pic.twitter.com/UcPPibuz5y
Today, the @US_FDA issued the draft guidance: Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters – Premarket Notification (510(k)) Submissions. pic.twitter.com/UcPPibuz5y (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - January 10, 2020 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Peripheral percutaneous transluminal angioplasty (PTA) balloons and specialty catheters are devices intended to treat lesions in the peripheral vascular system.
(Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - January 10, 2020 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Clopidogrel Appropriate for PCI in Liver Transplant Candidates Clopidogrel Appropriate for PCI in Liver Transplant Candidates
In patients with decompensated cirrhosis undergoing percutaneous coronary intervention (PCI), clopidogrel safely inhibits platelet aggregation, according to a small study of liver-transplant candidates.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 8, 2020 Category: Surgery Tags: Cardiology News Source Type: news

Percutaneous Coronary Intervention (PCI)
Title: Percutaneous Coronary Intervention (PCI)Category: Procedures and TestsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/3/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 3, 2020 Category: Cardiology Source Type: news

Welcome Data Show Two Sides of PCI in Patients With Cancer Welcome Data Show Two Sides of PCI in Patients With Cancer
Although more patients with cancer are living longer and are undergoing percutaneous coronary intervention, data are scarce on contemporary stent performance.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - December 31, 2019 Category: Surgery Tags: Cardiology News Source Type: news

In the U.S., an angioplasty costs $32,000. Elsewhere? Maybe $6,400.
As politicians continue to lament the system ’s expense, and more Americans struggle to pay the high and often unpredictable bills that can accompany their health problems, it’s worth looking at just how weird our prices really are relative to the rest of the world. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 27, 2019 Category: Pharmaceuticals Authors: Margot Sanger-Katz Source Type: news

In the U.S., an Angioplasty Costs $32,000. Elsewhere? Maybe $6,400.
A study of international prices finds American patients pay much more across a wide array of common services. (Source: NYT)
Source: NYT - December 27, 2019 Category: American Health Authors: Margot Sanger-Katz Tags: Prices (Fares, Fees and Rates) Health Insurance and Managed Care Presidential Election of 2020 Hospitals Source Type: news

20 Private Companies to Watch in 2020
MD+DI has taken a hard look at the private medtech sector and developed this list of 20 private companies we will be paying particularly close attention to in the new year. It was not an easy task. There are so many interesting private companies in the industry right now that we started with a much longer list and whittled it down to the 20 companies that stood out most to us. So without further ado, here are the 20 companies that made the cut: 4C Medical is developing the AltaValve, a transcatheter mitral valve replacement (TMVR) platform designed to address mitr...
Source: MDDI - December 24, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

20 Private Medtech Companies to Watch in 2020
MD+DI has taken a hard look at the private medtech sector and developed this list of 20 private companies we will be paying particularly close attention to in the new year. It was not an easy task. There are so many interesting private companies in the industry right now that we started with a much longer list and whittled it down to the 20 companies that stood out most to us. So without further ado, here are the 20 companies that made the cut: 4C Medical is developing the AltaValve, a transcatheter mitral valve replacement (TMVR) platform designed to address mitr...
Source: MDDI - December 24, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

University Hospital Giessen Performs First Minimally Invasive, Robotic-Assisted Coronary Intervention in Germany
The University Hospital Giessen is the first hospital in Germany where a robotic system assists in a minimally invasive procedure to place a stent into a narrowed coronary artery to reopen it. This percutaneous coronary intervention (PCI) was carried out by the team of Prof. Holger Nef, Deputy Clinical Director Medical Clinic I, Cardiology and Angiology, University Giessen. (Source: eHealth News EU)
Source: eHealth News EU - December 18, 2019 Category: Information Technology Tags: Featured Siemens Healthineers Business and Industry Source Type: news

Can 3D Modeling Replace a Guidewire-Based Cardiac Procedure?
The CathWorks FFRangio System, which received FDA clearance in late last year, has just been approved by the Japan's Ministry of Health, Labour and Welfare (MHLW). Designed for use during angiography, the non-invasive diagnostic tool turns routine angiogram images into color-coded 3D renderings of blood flow in the heart's arteries. Physicians can then use the images to determine whether a stent is needed. “The CathWorks FFRangio System automatically receives the angiograms in DiCOM format from the C-ARM (X-Ray) systems at the time of angiogram procedure,” Ramin Mousavi, vice president,&...
Source: MDDI - December 17, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Cardiovascular Source Type: news

5 More Private Medtech Companies to Keep Tabs On
MedTech analysts continue to keep a watchful eye on the private sector. Needham & Co.'s Mike Matson recently called attention to five private medical device companies he finds interesting, adding to three previous lists the analyst published earlier this year. Matson was not the only medtech analyst keeping tabs on up and coming private companies in 2019. In January, Canaccord Genuity's Jason Mills highlighted 16 potentially disruptive medtech companies in the private sector. Here are the five companies Matson most recently highlighted. 7D Surgical...
Source: MDDI - December 16, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news